Download FREE Report Sample
Download Free sampleAndrogenetic alopecia (AGA) is a patterned hair loss occurring due to systemic androgen and genetic factors. It is the most common cause of hair loss in both genders. It is characterized by follicular miniaturization in a patterned hair loss occurring due to systemic androgen and genetic factors.
Androgenetic Alopecia Treatment Market contains market size and forecasts of Androgenetic Alopecia Treatment in Global, including the following market information:
Global Androgenetic Alopecia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Androgenetic Alopecia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Topical Agents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Androgenetic Alopecia Treatment include Histogen Inc, Cipla Limited, Aclaris Therapeutics, Inc, Merck & Co., Inc, Daiichi-Sankyo Co., Ltd, Johnson and Johnson Services, Inc, Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH and PureTech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Androgenetic Alopecia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Androgenetic Alopecia Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Androgenetic Alopecia Treatment Market Segment Percentages, by Type, 2021 (%)
Topical Agents
5 AR Inhibitors
Others
Global Androgenetic Alopecia Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Androgenetic Alopecia Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Androgenetic Alopecia Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Androgenetic Alopecia Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Androgenetic Alopecia Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Androgenetic Alopecia Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Histogen Inc
Cipla Limited
Aclaris Therapeutics, Inc
Merck & Co., Inc
Daiichi-Sankyo Co., Ltd
Johnson and Johnson Services, Inc
Lexington International LLC
Vita-Cos-Med Klett-Loch GmbH
PureTech
Vitabiotics
Dr. Reddy?s Laboratories
HCell Inc
Follica, Inc
Ranbaxy Laboratories Ltd.
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
